TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33252169

Group type: EXPERIMENTAL
Intervention: Self-Completion (SC) of the Edmonton Symptom Assessment Scale (ESAS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Assisted Completion (AC) by a nurse
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Self-Completion (SC) with nurse review
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Lower literacy (REALM) score and shortness of breath
Number of subjects: 126
Study: 35535057

Group type: EXPERIMENTAL
Intervention: Rifaximin (550 mg twice daily)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Norfloxacin (400 mg once daily)
Number of subjects: 132
Study: 33781125

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Brazilian Dietary Guidelines (16 hours of training)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4
Study: 34514739

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 33684643

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Methylphenidate and Placebo
Number of subjects: 45
Study: 33938613

Group type: EXPERIMENTAL
Intervention: Fish consumption (6% of diet)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Soda consumption (14% of diet)
Number of subjects: 26
Study: 33223425

Group type: EXPERIMENTAL
Intervention: RestoreX Penile Traction Therapy (PTT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: No therapy (control)
Number of subjects: 110
Study: 34266853

Group type: EXPERIMENTAL
Intervention: Surgery as part of multimodality treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: No surgery as part of multimodality treatment
Number of subjects: 66
Study: 33136243

Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 questionnaire
Number of subjects: 1107
Study: 36307755

Group type: EXPERIMENTAL
Intervention: M-TAPA block performed bilaterally after the induction of general anesthesia
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: M-TAPA block
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no block performed)
Number of subjects: 68
Study: 34245234

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR) for 10 days post-surgery
Number of subjects: 158

Group type: COMPARATOR
Intervention: Home program alone
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR) and home program
Number of subjects: 158
Study: 33078599

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus carboplatin (TC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Irinotecan plus cisplatin (CPT-P)
Number of subjects: 166
Study: 35912312

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy and occupation-based bilateral upper limb training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional occupational therapy and occupation-based bilateral upper limb training
Number of subjects: 0
Study: 34197166

Group type: EXPERIMENTAL
Intervention: Positive parent-child images
Number of subjects: 1093

Group type: EXPERIMENTAL
Intervention: Negative parent-child images
Number of subjects: 1093

Group type: COMPARATOR
Intervention: Control images
Number of subjects: 1093
Study: 32921367

Group type: EXPERIMENTAL
Intervention: Routine, staged, angiographically guided nonculprit lesion PCI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment of nonculprit lesions
Number of subjects: 0
Study: 32656955

Group type: EXPERIMENTAL
Intervention: HRpre images generated by DCGAN
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: HRpost images generated by DCGAN
Number of subjects: 224

Group type: COMPARATOR
Intervention: Image quality scores, lesion conspicuity scores, and BI-RADS categories
Number of subjects: 224
Study: 36442300

Group type: EXPERIMENTAL
Intervention: Three-in-1000 appeal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic norms appeal
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-message control group
Number of subjects: 0
Study: 33998004

Group type: EXPERIMENTAL
Intervention: Minoxidil with photobiomodulation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Minoxidil only
Number of subjects: 21
Study: 35577469

Group type: EXPERIMENTAL
Intervention: T‐CRF intervention (24-week programme of three telehealth nurse‐led consultations and a personalised CRF management plan)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (specialist‐led care with a fatigue information booklet)
Number of subjects: 60
Study: 33230541

Group type: EXPERIMENTAL
Intervention: Op Koers Online (online psychosocial group intervention)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 73
Study: 35294908

Group type: EXPERIMENTAL
Intervention: Low concentration/dose groups (370-0.7, 300-1.0, and 300-0.9)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low injection rate groups (2-370 and 2-350)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: VMI60 keV
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (standard contrast agent protocol)
Number of subjects: 102
Study: 34579009

Group type: EXPERIMENTAL
Intervention: Citrulline supplementation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32871808

Group type: EXPERIMENTAL
Intervention: TP‐CCRT (cisplatin plus paclitaxel)
Number of subjects: 30

Group type: COMPARATOR
Intervention: P‐CCRT (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TP‐CCRT
Number of subjects: 30

Group type: COMPARATOR
Intervention: P‐CCRT
Number of subjects: 30
Study: 36447145

Group type: EXPERIMENTAL
Intervention: Alternate part-time patching
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Pencil push-up training
Number of subjects: 92

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 92
Study: 34535143

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) cholesterol
Number of subjects: 361194

Group type: EXPERIMENTAL
Intervention: Total cholesterol (TC)
Number of subjects: 361194

Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 361194

Group type: EXPERIMENTAL
Intervention: High-density lipoprotein (HDL) cholesterol
Number of subjects: 361194
Study: 32236395

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT) program (TEAM‐V)
Number of subjects: 40
Study: 35486946

Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music) for 18 sessions over six weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 48
Study: 33858011

Group type: EXPERIMENTAL
Intervention: Cannabis oil containing 160/40 mg/ml cannabidiol/tetrahydrocannabinol (CBD/THC) for 8 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 56
Study: 33642460

Group type: EXPERIMENTAL
Intervention: Knowledge about vitamin A fortified edible oils
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Knowledge about vitamin A fortified rice
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Consumption of vitamin A fortified edible oils
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Consumption of vitamin A fortified rice
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Knowledge and consumption rates
Number of subjects: 400
Study: 32331983

Group type: EXPERIMENTAL
Intervention: D2 lymph node dissection (LND)
Number of subjects: 1121

Group type: COMPARATOR
Intervention: D1+ lymph node dissection (LND)
Number of subjects: 1121
Study: 34241691

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3442

Group type: EXPERIMENTAL
Intervention: Non-TNF biologics
Number of subjects: 3442

Group type: EXPERIMENTAL
Intervention: JAK inhibitors
Number of subjects: 3442
Study: 33621423

Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison between L-NMMA and Saline
Number of subjects: 25
Study: 33142537

Group type: EXPERIMENTAL
Intervention: 30 mg/kg Mn
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20 mg/kg Mn
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 5 × 10^9 CFU/kg BS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20 and 30 mg/kg Mn and 5 × 10^9 CFU/kg BS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20 and 30 mg/kg Mn
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mn and BS
Number of subjects: 120
Study: 35060855

Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-fidelity simulation (control)
Number of subjects: 0
Study: 34229655

Group type: EXPERIMENTAL
Intervention: Duo positive airway pressure (NDUOPAP)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 148
Study: 34655765

Group type: EXPERIMENTAL
Intervention: Automated mobile phone text messages for 90 days
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard perioperative communication
Number of subjects: 121
Study: 33050752

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 88
Study: 36544645

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg remimazolam tosylate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg remimazolam tosylate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg remimazolam tosylate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 33363715

Group type: EXPERIMENTAL
Intervention: anodal transcranial direct current stimulation (atDCS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 16
Study: 35095080

Group type: EXPERIMENTAL
Intervention: Mild WMH (0.26% ± 0.14% of ICV)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Moderate WMH (0.70% ± 0.15% of ICV)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Severe WMH (1.75% ± 0.67% of ICV)
Number of subjects: 78
Study: 34090464

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (100 mg/kg IV, 3 doses: 2 intraoperative and 1 postoperative)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study: 35025723

Group type: EXPERIMENTAL
Intervention: Sham tDCS with caffeine intake (Sham+Caff)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anodal tDCS with caffeine intake (a-tDCS+Caff)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anodal tDCS with placebo intake (a-tDCS+Pla)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS with placebo intake (Sham+Pla)
Number of subjects: 16
Study: 34426097

Group type: EXPERIMENTAL
Intervention: Community health worker-led decision-coaching program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32970478

Group type: EXPERIMENTAL
Intervention: SBRT by linear accelerator (Linac)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Cyberknife®
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: SBRT by linear accelerator (Linac) and Cyberknife®
Number of subjects: 106
Study: 33630716

Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program - After-School version (CHP-AS)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program - Mentoring version (CHP-M)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Routine community care
Number of subjects: 326
Study: 33956387

Group type: EXPERIMENTAL
Intervention: MET + IIT
Number of subjects: 108

Group type: COMPARATOR
Intervention: MET
Number of subjects: 108
Study: 36038376

Group type: EXPERIMENTAL
Intervention: Mixed reality mentoring
Number of subjects: 14

Group type: COMPARATOR
Intervention: Audio-only mentoring
Number of subjects: 14
Study: 34684600

Group type: EXPERIMENTAL
Intervention: Motivational Nutritional Intervention through Social Networks 2.0
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study: 35201518

Group type: EXPERIMENTAL
Intervention: Inflawell® syrup (Boswellia extract formulation enriched for boswellic acids)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 33904391

Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD) during sleep
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral appliance (sham MAD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 18

Group type: COMPARATOR
Intervention: First dorsal interosseous muscle (control)
Number of subjects: 18
Study: 36041962

Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 311

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 311
Study: 35124400

Group type: EXPERIMENTAL
Intervention: MDMA (75 mg)
Number of subjects: 60
Study: 33164319

Group type: EXPERIMENTAL
Intervention: Reactive ATP
Number of subjects: 146

Group type: COMPARATOR
Intervention: DDD RP (from MINERVA trial)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control DDDR (from MINERVA trial)
Number of subjects: 146

Group type: COMPARATOR
Intervention: MVP (from MINERVA trial)
Number of subjects: 146
Study: 34856171

Group type: EXPERIMENTAL
Intervention: MLC901 (NeuroAiD II)
Number of subjects: 125
Study: 33203405

Group type: EXPERIMENTAL
Intervention: Screening and patient-tailored care for cognitive and emotional problems, including a short, individualized, semi-structured consultation by specialized nurses, screening for cognitive and emotional problems, screening for restrictions in participation, promotion of self-management strategies, and a decision tool for referral to rehabilitation services, performed approximately 6 weeks after the stroke for about 60 minutes.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 0
Study: 34896443

Group type: EXPERIMENTAL
Intervention: Epinephrine in submucosal injectate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injectate alone (Control)
Number of subjects: 0
Study: 33248438

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) at 30% of maximal inspiratory pressure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo Inspiratory Muscle Training (P‐IMT) at 2% of maximal inspiratory pressure
Number of subjects: 30
Study: 36033577

Group type: EXPERIMENTAL
Intervention: Single-port thoracoscopic surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: Three-port thoracoscopic surgery
Number of subjects: 68
Study: 32073145

Group type: EXPERIMENTAL
Intervention: Endoscopic ossiculoplasty with PORP
Number of subjects: 118

Group type: COMPARATOR
Intervention: Microscopic ossiculoplasty with PORP
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: TORP ossiculoplasty
Number of subjects: 118

Group type: COMPARATOR
Intervention: Endoscopic ossiculoplasty and Microscopic ossiculoplasty
Number of subjects: 118
Study: 35148378

Group type: EXPERIMENTAL
Intervention: Cefiderocol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Best-available therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-dose meropenem
Number of subjects: 24
Study: 34366152

Group type: EXPERIMENTAL
Intervention: Lasmiditan (100 mg and 200 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Lasmiditan
Number of subjects: 132
Study: 32291607

Group type: EXPERIMENTAL
Intervention: Thick-needle therapy (TNT)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Acupuncture therapy (AT)
Number of subjects: 146
Study: 34959111

Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation (rTMS) treatment twice a week
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 32
Study: 33377957

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both (Ephedrine and Phenylephrine)
Number of subjects: 24
Study: 36367835

Group type: EXPERIMENTAL
Intervention: SHIFT intervention (6-month duration)
Number of subjects: 25
Study: 33228794

Group type: EXPERIMENTAL
Intervention: Planned early delivery (initiation of delivery within 48 h of randomisation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (expectant management)
Number of subjects: 0
Study: 37575887

Group type: EXPERIMENTAL
Intervention: Text-only warning labels
Number of subjects: 3051

Group type: EXPERIMENTAL
Intervention: Icon warning labels
Number of subjects: 3051

Group type: EXPERIMENTAL
Intervention: Warnings about addiction
Number of subjects: 3051

Group type: COMPARATOR
Intervention: Control labels
Number of subjects: 3051
Study: 33773084

Group type: EXPERIMENTAL
Intervention: Automated control of FiO2 using PRICO® system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual control of FiO2
Number of subjects: 20
Study: 35129064

Group type: EXPERIMENTAL
Intervention: Home Exercise Assessment Tool (HEAT)
Number of subjects: 30
Study: 33611615

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) every 3 months for 18 months
Number of subjects: 3046

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3046
Study: 34342608

Group type: EXPERIMENTAL
Intervention: Three-dimensional visualization system (3D group)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Traditional microscope (TM group)
Number of subjects: 201
Study: 32108262

Group type: EXPERIMENTAL
Intervention: Juçara group (5 g lyophilized juçara)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo group (5 g of maltodextrin)
Number of subjects: 35
Study: 36135712

Group type: EXPERIMENTAL
Intervention: Trilaciclib prior to gemcitabine plus carboplatin (GCb)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemcitabine plus carboplatin (GCb) alone
Number of subjects: 0
Study: 33031748

Group type: EXPERIMENTAL
Intervention: Genome-wide association analysis of circulating metabolites
Number of subjects: 3926

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) analysis
Number of subjects: 3926
Study: 35797640

Group type: EXPERIMENTAL
Intervention: Titanium clip-dental floss traction
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (standard ERCP without traction)
Number of subjects: 68
Study: 33837473

Group type: EXPERIMENTAL
Intervention: Standardized scripts offering an interpreter (three unique scripted questions)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Scripted question: 'In what language do you prefer to receive your medical care?'
Number of subjects: 55
Study: 36227931

Group type: EXPERIMENTAL
Intervention: Home-based physical exercise intervention supported by a mobile application
Number of subjects: 712

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 712
Study: 33846866

Group type: EXPERIMENTAL
Intervention: Nalmefene (18 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 32372078

Group type: EXPERIMENTAL
Intervention: Endometrial injury (scratching)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 35187877

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 34795208

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35658650

Group type: EXPERIMENTAL
Intervention: Traditional Ankle Pump Exercise (3 times/min)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Selected Ankle Pump Exercise (30 times/min)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 307
Study: 33151787

Group type: EXPERIMENTAL
Intervention: PET/CT scans at premaintenance (PM)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: FS and BMS < 4
Number of subjects: 228
Study: 35599921

Group type: EXPERIMENTAL
Intervention: Betaine (2.5 g·d‐1)
Number of subjects: 10
Study: 37422602

Group type: EXPERIMENTAL
Intervention: Standard dose albumin (1.5 g/kg at diagnosis and 1 g/kg on day three, infused over six hours)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Reduced dose albumin (0.75 g/kg at diagnosis and 0.5 g/kg 48 hours later, infused over six hours)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Standard dose albumin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Reduced dose albumin
Number of subjects: 63
Study: 33058735

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention in addition to conventional cognitive rehabilitation (CR)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional cognitive rehabilitation (CR)
Number of subjects: 61
Study: 32358661

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) injection
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Peptide (Prostrolane®) injection
Number of subjects: 54

Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 54
Study: 34535524

Group type: EXPERIMENTAL
Intervention: Practice Facilitation (PF) for 1 year
Number of subjects: 32
Study: 32506481

Group type: EXPERIMENTAL
Intervention: Individualized pneumoperitoneum pressure (IPP) strategy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard pneumoperitoneum pressure (SPP) strategy
Number of subjects: 166
Study: 36037232

Group type: EXPERIMENTAL
Intervention: Personalized interventions using the Well‐Beat system
Number of subjects: 95

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 95
Study: 32081036

Group type: EXPERIMENTAL
Intervention: Circadian insulin infusion rates
Number of subjects: 17

Group type: COMPARATOR
Intervention: Flat insulin infusion rates
Number of subjects: 17
Study: 32771068

Group type: EXPERIMENTAL
Intervention: Online self-help leaflet intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 60
Study: 34320937

Group type: EXPERIMENTAL
Intervention: Bright light treatment (BLT) using ceiling mounted LED-panels providing light at 1000 lx and 6000 K between 10 a.m. and 3 p.m.
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Bright light treatment (BLT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard indoor light (control group)
Number of subjects: 69